AMAROGENTINE

Amarogentin is a bitter secoiridoid compound with digestive‑stimulating and anti‑inflammatory properties. Benefits include enhanced appetite and digestive function. Side effects are rare but may include stomach discomfort.

SKU: 14881f38e716 Category: Tag:

Product Description


Mechanism of action

Amarogentine is a highly bitter secoiridoid glycoside found in gentian species. It stimulates bitter taste receptors (T2Rs) on the tongue and in the upper gastrointestinal tract. Activation of these receptors triggers neural reflexes that enhance salivary, gastric and biliary secretions and may influence appetite and digestive motility.

Benefits and advantages

Amarogentine is used primarily as a standard bitter principle in pharmaceutical and nutraceutical formulations, and as a reference substance in sensory evaluation and bitterness-testing systems. In traditional and modern phytotherapy, amarogentine-containing extracts are employed as digestive tonics to support appetite and gastric function in cases of dyspepsia or reduced digestive capacity.

Side effects and risks

At typical bitter-dose levels, adverse effects are uncommon but may include gastric discomfort or nausea in sensitive individuals. Very high doses could potentially exacerbate acid-related disorders such as peptic ulcer disease. Because amarogentine is intensely bitter, care must be taken in handling and formulation to avoid contamination of other products and to ensure acceptable palatability profiles.

Professional use only. Supplied exclusively to licensed manufacturers, laboratories and institutions.

Datasheet


Molecular Formula

C29H30O13

Molecular Weight

586.5 g/mol

CAS Number

21018-84-8

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

Amarogentin; 21018-84-8; 5L82GT5I0W; DTXSID501029787; [(2S,3R,4S,5S,6R)-2-[[(3S,4R,4aS)-4-ethenyl-8-oxo-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyran-3-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] 2,4-dihydroxy-6-(3-hydroxyphenyl)benzoate

IUPAC/Chemical Name

Bitter secoiridoid glycoside

InChl Key

ZNECFYBFMOKWKH-UTQWQCRQSA-N

InChl Code

InChI=1S/C29H30O13/c1-2-16-17-6-7-38-26(36)19(17)12-39-28(16)42-29-25(24(35)23(34)21(11-30)40-29)41-27(37)22-18(9-15(32)10-20(22)33)13-4-3-5-14(31)8-13/h2-5,8-10,12,16-17,21,23-25,28-35H,1,6-7,11H2/t16-,17+,21-,23-,24+,25-,28+,29+/m1/s1

References

https://pubchem.ncbi.nlm.nih.gov/#query=21018-84-8;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download